Shanghai - Delayed Quote • CNY
Ginwa Enterprise (Group) Inc. (600080.SS)
At close: April 19 at 3:00 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Yajuan Ju | Financial Director | -- | -- | 1981 |
Mr. Boyue Xing | Deputy GM & Director | -- | -- | 1996 |
Mr. Ming Sun | Board Secretary | -- | -- | 1972 |
Ginwa Enterprise (Group) Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 600
Description
Ginwa Enterprise (Group) Inc. researches, develops, produces, and sells pharmaceuticals in China. The company offers orthopedic, immune, pediatric, antibiotic, digestive system, gynecological, cardiovascular, antipyretic, analgesic, antiviral, and other products. It offers its products in the form of tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. In addition, the company provides chemical drugs, Chinese medicines, raw materials, and health related products. Ginwa Enterprise (Group) Inc. was founded in 1996 and is based in Xi'an, China.
Corporate Governance
Ginwa Enterprise (Group) Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Jun 17, 2021Ex-Dividend Date
Upcoming Events
Upcoming Events Information Not Available